Moderna, Pfizer forecast for a combined $93.2B in COVID vaccine sales in 2022 - FT

seekingalpha2021-10-18

Moderna, Inc. and Pfizer/BioNTech SE are forecast to have a combined $93.2B in COVID-19 vaccine sales next year, theFinancial Timesreports. That estimate comes from health data analytics firm ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • DZL
    2021-10-18
    DZL
    Moderna, Pfizer, raking in continued revenuefrom vaccine sales
    • DZL
      steady growth from sustained vaccine demand
  • lee1234
    2021-10-18
    lee1234
    Like
  • Birdykoh
    2021-10-18
    Birdykoh
    Wow
  • Pluto891
    2021-10-18
    Pluto891
    all about money. No charity. 
    • KLS
      Buy
    • BlueDaisy
      If it is for charity, gotta dump the stock!
  • Gummybear
    2021-10-18
    Gummybear
    Sure
  • Suba
    2021-10-18
    Suba
    Ok
发表看法
11